, Tracking Stock Market Picks
Enter Symbol:
Allergan, Inc. (AGN) [hlAlert]

up 1.22 %

Allergan, Inc. (AGN) rated Buy with price target $97 by Deutsche Bank

Posted on: Friday,  Sep 16, 2011  2:25 PM ET by Deutsche Bank

Deutsche Bank rated Buy Allergan, Inc. (NYSE: AGN) on 09/16/2011, when the stock price was $82.71. Since then, Allergan, Inc.
has gained 1.22% of its value until Deutsche Bank rated AGN Hold on 06/24/2013, when the price was $83.72.
If you would have followed this Deutsche Bank's recommendation on AGN, you would have gained 1.22% of your investment in 647 days.

Allergan, Inc. is a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics and medical devices. The Company is engaged in discovering, developing and commercializing specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in more than 100 countries globally. In January 2007, the Company completed the acquisition of Groupe Corneal Laboratoires (Corneal). In October 2007, the Company completed the acquisition of Esprit Pharma Holding Company, Inc. (Esprit). In July 2008, the Company acquired the Aczone (dapsone) gel 5% from QLT USA, Inc. (QLT), a wholly owned subsidiary of QLT Inc. The Company operates in two business segments: specialty pharmaceuticals and medical devices.

Deutsche Bank is one of the largest European fund managers. DWS was founded in 1956 and is an integral part of the Asset Management division of Deutsche Bank. This division is one of the largest global asset managers.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/9/2014 3:25 PM Buy
188.64 215.00
as of 12/30/2011
1 Week up  0.36 %
1 Month up  4.80 %
3 Months up  6.50 %
1 YTD up  6.08 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/24/2013 2:25 PM Hold
9/16/2011 2:25 PM Buy
82.71 97.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy